AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout the research process. “The value of AI in our industry is productivity improvement,” Soriot said on CNBC’s “Mad Money” on Friday. “In the way you design a new medicine, a new drug, you can actually do it … Read more
One of America’s largest pharmaceutical companies this week said it will partner with a Chinese drugmaker to test some of its experimental drugs and discover new ones, a deal that could mark the next phase of coordination across continents. Bristol Myers Squibb on Tuesday announced the potential multi-billion dollar partnership with one of China’s top … Read more
Check out the companies making the biggest moves premarket: Akamai Technologies — Shares surged 27% after the cybersecurity and cloud computing company said a leading U.S.-based frontier model provider has committed to $1.8 billion over seven years for its Cloud Infrastructure Services. Akamai also reported a first-quarter adjusted earnings beat, while its revenue came in … Read more
Check out the companies making headlines after the bell : CoreWeave — The cloud infrastructure company slid about 10% as its second-quarter revenue guidance disappointed Wall Street. CoreWeave sees revenue ranging from $2.45 billion to $2.6 billion. The midpoint of $2.53 billion fell short of the $2.69 billion LSEG consensus call. Gen Digital — The … Read more
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, … Read more
Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September 19, 2024 in London, England. Leon Neal | Getty Images News | Getty Images Once the go-to location for global drugmakers, Europe is now being squeezed by President Donald Trump’s aggressive trade and drug-pricing … Read more
A year after President Donald Trump declared his “liberation day” and imposed sweeping tariffs on imports, kicking off a wave of economic and political uncertainty, some companies are still feeling the effects. While some industries have emerged largely unscathed — having weathered twists and turns of several tariff iterations — others, such as retail, automotive, … Read more
US President Donald Trump (C), alongside Secretary of Health and Human Services Robert F. Kennedy Jr. (R) and National Institute of Health (NIH) Director Jayanta Bhattacharya (L), speaks during a news conference about prescription drug prices, in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Jim Watson | Afp … Read more
A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove … Read more
Check out the companies making the biggest moves premarket: AstraZeneca — The pharma giant rose 3% after its experimental drug, tozorakimab, was found to meaningfully reduce flare-ups in cases of chronic obstructive pulmonary disease. The drug delivered the results in two late-stage trials, and the company said full results will be delivered at an upcoming … Read more